Kyverna Therapeutics, Inc. (KYTX) — Dilution Risk Analysis

Current Snapshot

Kyverna Therapeutics, Inc. (KYTX) has a DilutionWatch score of 52/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
61,843,444 Source
Public Float
35,501,972 Source
Float as % of Outstanding
57.4%

Dilution Risk Score

Score: 52/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

2 shelf registration or ATM offering filings detected in recent history.

Recent filing forms in the source payload: 424B5 1, EFFECT 1, S-3 1, 4 5, 3 2.

FormFiledAccession
424B5 2026-04-02 0001193125-26-140377
EFFECT 2026-04-02 9999999995-26-001072
S-3 2026-03-26 0001193125-26-126321
4 2026-03-17 0001193125-26-110941
4 2026-03-17 0001193125-26-110920
4 2026-03-17 0001193125-26-110934
4 2026-03-04 0001193125-26-091626
3 2026-03-04 0001193125-26-091628
3 2026-02-26 0001193125-26-076896
4 2026-02-26 0001193125-26-076897

Dilution Risk Drivers

DriverStored ValueSource
Shelf registration capacity $300,000,000 Source
ATM offering capacity remaining $100,000,000 Source
Cash runway 19 months Source
Three-year share count growth 48.93% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 52/10) Source
Cash Runway
19 months Source
ATM Offering Capacity Remaining
$100,000,000 Source
Shelf Registration Capacity
$300,000,000 Source
Share Count Growth (3-Year)
48.93% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.